Document is current
Any future updates will be listed below
-
Authors
Pinto, Álvaro https://orcid.org/0000-0002-4719-053X
Miranda, Jesús
Pertejo, Ana
Álvarez-Maestro, Mario
González-Peramato, Pilar
Aguilera, Alfredo
García, Eugenia
Trilla, Lucía
Gámez, Ángelo
Espinosa, Enrique
- License Information
-
More Information
Article History
Received: 8 May 2023
Accepted: 3 July 2023
First Online: 28 July 2023
Declarations
:
: Álvaro Pinto: Speaker fees—advisory board: Janssen, Astellas, Pfizer, GSK, Novartis, Ipsen, Bristol-Myers-Squibb, MSD, Eisai, Bayer. Research grants: Pfizer, Bristol-Myers-Squibb. Ana Pertejo: Speaker fees—advisory board: Janssen, Astellas. The rest of the authors do not have relevant conflicts of interest to disclose.
: The study was approved by the Ethics Committee of Hospital Universitario La Paz, project PI-3310. This was a retrospective, non-interventional study, so there was no formal sample processing or research involving humans.
: Informed consent was obtained from all patients.
